148 related articles for article (PubMed ID: 8813121)
21. Direct correlation between FRA3B expression and cigarette smoking.
Stein CK; Glover TW; Palmer JL; Glisson BS
Genes Chromosomes Cancer; 2002 Jul; 34(3):333-40. PubMed ID: 12007194
[TBL] [Abstract][Full Text] [Related]
22. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma.
Kameoka Y; Tagawa H; Tsuzuki S; Karnan S; Ota A; Suguro M; Suzuki R; Yamaguchi M; Morishima Y; Nakamura S; Seto M
Oncogene; 2004 Dec; 23(56):9148-54. PubMed ID: 15480422
[TBL] [Abstract][Full Text] [Related]
23. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG
Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673
[TBL] [Abstract][Full Text] [Related]
24. Induction of the common fragile site FRA3B does not affect FHIT expression.
Michael D; Rajewsky MF
Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927
[TBL] [Abstract][Full Text] [Related]
25. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
26. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type.
Muller CY; O'Boyle JD; Fong KM; Wistuba II; Biesterveld E; Ahmadian M; Miller DS; Gazdar AF; Minna JD
J Natl Cancer Inst; 1998 Mar; 90(6):433-9. PubMed ID: 9521167
[TBL] [Abstract][Full Text] [Related]
27. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
[TBL] [Abstract][Full Text] [Related]
28. High resolution analysis of chromosome 3p alterations in cervical carcinoma.
Larson AA; Kern S; Curtiss S; Gordon R; Cavenee WK; Hampton GM
Cancer Res; 1997 Sep; 57(18):4082-90. PubMed ID: 9307297
[TBL] [Abstract][Full Text] [Related]
29. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
30. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.
Fang JM; Arlt MF; Burgess AC; Dagenais SL; Beer DG; Glover TW
Genes Chromosomes Cancer; 2001 Mar; 30(3):292-8. PubMed ID: 11170287
[TBL] [Abstract][Full Text] [Related]
31. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors.
Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834
[TBL] [Abstract][Full Text] [Related]
32. A novel approach to simultaneously scan genes at fragile sites.
Willem P; Brown J; Schouten J
BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
[TBL] [Abstract][Full Text] [Related]
33. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.
Boldog F; Gemmill RM; West J; Robinson M; Robinson L; Li E; Roche J; Todd S; Waggoner B; Lundstrom R; Jacobson J; Mullokandov MR; Klinger H; Drabkin HA
Hum Mol Genet; 1997 Feb; 6(2):193-203. PubMed ID: 9063739
[TBL] [Abstract][Full Text] [Related]
34. Common chromosomal fragile site FRA16D mutation in cancer cells.
Finnis M; Dayan S; Hobson L; Chenevix-Trench G; Friend K; Ried K; Venter D; Woollatt E; Baker E; Richards RI
Hum Mol Genet; 2005 May; 14(10):1341-9. PubMed ID: 15814586
[TBL] [Abstract][Full Text] [Related]
35. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: identification of a I-cM region of common allelic loss.
Kimura M; Abe T; Sunamura M; Matsuno S; Horii A
Genes Chromosomes Cancer; 1996 Oct; 17(2):88-93. PubMed ID: 8913725
[TBL] [Abstract][Full Text] [Related]
36. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
37. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
[TBL] [Abstract][Full Text] [Related]
38. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer.
Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI
Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108
[TBL] [Abstract][Full Text] [Related]
39. The role of the FHIT/FRA3B locus in cancer.
Huebner K; Garrison PN; Barnes LD; Croce CM
Annu Rev Genet; 1998; 32():7-31. PubMed ID: 9928473
[TBL] [Abstract][Full Text] [Related]
40. Deletion of the short arm of chromosome 3 in breast tumors.
Pandis N; Bardi G; Mitelman F; Heim S
Genes Chromosomes Cancer; 1997 Apr; 18(4):241-5. PubMed ID: 9087563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]